The Asia Pacific Bioprocess Bags Market would witness market growth of 17.4% CAGR during the forecast period (2023-2029).
The demand is anticipated to increase due to the increased outsourcing activities by Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs). Pharmaceutical and biotech companies can obtain manufacturing and research services from CMOs and CROs. The largest biopharma companies are increasingly using outside service providers for their bioprocessing needs, including creating, storing, and delivering biologics. Biologics manufacturing requires bioprocessing bags, and as more businesses outsource their bioprocessing operations, their demand is anticipated to rise.
The increasing number of biologics and the rise in research and development activities carried out by biopharmaceutical firms and academic institutions are the primary factors propelling the market. In addition, in biopharmaceuticals, there is a growing tendency toward modular production, which means that manufacturing processes are being scaled down into smaller, more flexible parts. Because they allow for the manufacturing of smaller batches, bioprocess bags are an essential component of this movement. As a result, they cut down on waste and boost productivity.
The International Diabetes Federation estimates that there will be 134 million diabetics in India by 2045, up from the current 77 million. Cardiovascular disease, which results in premature mortality, accounts for 25% of all fatalities in India. Urban and rural populations in India are seeing a sharp rise in hypertension. India's National Health Policy seeks to reduce early mortality from noncommunicable diseases (NCD) by one-third by 2030 in compliance with the Sustainable Development Goals. The increasing cases of chronic diseases will increase the demand and utilization of various treatment options, which will increase the manufacturing and research in the bioprocess settings, which will raise the application of bioprocess bags, thereby driving the market growth in the region.
The China market dominated the Asia Pacific Bioprocess Bags Market by Country in 2022 thereby, achieving a market value of $648.2 million by 2029. The Japan market is exhibiting a CAGR of 16.7% during (2023 - 2029). Additionally, The India market would experience a CAGR of 18.2% during (2023 - 2029).
Based on Workflow, the market is segmented into Upstream Process, Downstream Process and Process Development. Based on Type, the market is segmented into 2D, 3D and Others. Based on End-User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, CMOs & CROs and Academic & Research Institutes. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Bioprocess Bags Market is Projected to reach USD 7.8 Billion by 2029, at a CAGR of 16.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Sartorius AG, Danaher Corporation, Saint-Gobain Group, Corning Incorporated, Meissner Filtration Products, Inc., Merck KGaA, Entegris, Inc., PROAnalytics, LLC, and CellBios Healthcare and Lifesciences Pvt Ltd.
By Workflow
By Type
By End-User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 